Q321 Market Recap: US Surgical Matrices

Written by Doug Devens | 12/6/21 7:00 PM

Procedures using surgical matrices maintained their new normal, with broad strength in both hernia and breast matrices.

Procedures using surgical matrices maintained their new normal, though the resurgence of Delta variant across the northern tier of states may put a dent in the market following deferrals of procedures in various regions as the COVID-19 Delta variant caused more procedural headwinds.

Among the many topics covered in detail in our comprehensive Q321 US Surgical Matrices Market Recap* are:

Complete Q321 US Surgical Matrices Market Overview
SmartTRAK's Expert Analysis and Insights
All Market News including Revenues, Data, Charts and Shares
US Surgical Matrices Market Makes It Back To Pre-COVID-19 Levels
US Breast Matrices: Back In Business
US Hernia Repair Matrices Market: Solid Growth In Q321
Important Q321 Market Events

The US Surgical Matrices market gained steam in Q321, gaining +10.0% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie continued to lead the Surgical Matrices market, gaining +21.0% YoY. Becton Dickinson (BD) also grew well, gaining +7.1% YoY and ...

Read the entire Q321 US Surgical Matrices Market Recap, including news, data, charts, company revenues, shares and our expert analysis*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

SmartTRAK has recently expanded it's coverage to include five new modules. Click to see details of all the exciting new additions to the SmartTRAK platform in 2021.

View full post